Clinical Trial Update: Iberdomide, Daratumumab, Carfilzomib, and Dexamethasone (Iber-KDd) in Patients With Relapsed/Refractory Multiple Myeloma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating Iberdomide with Daratumumab, Carfilzomib, and Dexamethasone (Iber-KDd) for relapsed or refractory multiple myeloma; the study is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DARZALEX (daratumumab)
• DEXAMETHASONE (Dexamethasone)
• Kyprolis (carfilzomib)
• iberdomide (iberdomide)

Snippet

Sponsor: Benjamin T Diamond, MD | Conditions: Refractory Multiple Myeloma, Relapsed Multiple Myeloma | Phase 2 | Status: RECRUITING